SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 353 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $262,000 | +13.4% | 1,537 | -6.5% | 0.02% | -22.2% |
Q3 2020 | $231,000 | +0.9% | 1,643 | +15.1% | 0.03% | -38.6% |
Q2 2020 | $229,000 | -66.8% | 1,428 | -73.3% | 0.04% | -22.8% |
Q4 2019 | $689,000 | +88.8% | 5,343 | +10.1% | 0.06% | +78.1% |
Q3 2019 | $365,000 | -57.0% | 4,852 | -13.1% | 0.03% | -60.0% |
Q2 2019 | $849,000 | +9.5% | 5,585 | -14.1% | 0.08% | +11.1% |
Q1 2019 | $775,000 | -21.2% | 6,502 | -27.8% | 0.07% | -23.4% |
Q4 2018 | $983,000 | +32.3% | 9,008 | +95.8% | 0.09% | +54.1% |
Q3 2018 | $743,000 | +68.5% | 4,600 | +37.8% | 0.06% | +48.8% |
Q2 2018 | $441,000 | +83.0% | 3,337 | +2.7% | 0.04% | +86.4% |
Q1 2018 | $241,000 | – | 3,249 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |